Internal Medicine, Rheumatology · Denver, CO
NPI
1245297555
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
4500 E 9th Ave, 500 S
Denver, CO, 80220
Phone (303) 861-2190
Groups this clinician bills Medicare through
Medicare paid, 2024
$584K
47,785 services
Medicare patients, 2024
316
Average age 74
Drug cost, 2024
$2.2M
2,532 prescriptions
Company payments, 2025
$2,707
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David S Korman was code J0897 (injection, denosumab, 1 mg), 4,380 times for 45 patients. In total David S Korman billed 47,785 services in 42 codes, and Medicare paid $584K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 4,380 | 45 | $20.44 | $90K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 880 | 16 | $0.10 | $92.13 |
| 99214 Office E&M - Established | Office | 426 | 217 | $81.76 | $35K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 261 | 165 | $11.49 | $3,000 |
| J3489 Injection, zoledronic acid, 1 mg | Office | 160 | 32 | $4.94 | $790 |
| 96372 Injection Administration | Office | 142 | 53 | $10.49 | $1,489 |
| 96365 Intravenous Infusion, Hydration | Office | 92 | 40 | $45.46 | $4,182 |
| 96415 Chemotherapy Administration | Office | 80 | 12 | $19.60 | $1,559 |
| 96413 Chemotherapy Administration | Office | 62 | 14 | $94.52 | $5,860 |
| 99204 Office E&M - New | Office | 57 | 57 | $112.54 | $6,415 |
| 77080 Standard X-ray | Office | 28 | 28 | $36.02 | $1,009 |
| 77085 Standard X-ray | Office | 19 | 19 | $49.33 | $937 |
| 99213 Office E&M - Established | Office | 15 | 14 | $59.94 | $899 |
| 99205 Office E&M - New | Office | 15 | 15 | $137.72 | $2,066 |
By year: 2022 $543K for 31,651 services; 2023 $541K for 43,054 services; 2024 $584K for 47,785 services.
Medicare prescription drug claims, 2024
In 2024, the drug David S Korman prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 326 prescriptions and refills. In total David S Korman wrote 2,532 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 326 | 676 | 74 | $10K |
| Prednisone Generic | 280 | 460 | 101 | $2,171 |
| Methotrexate Methotrexate Sodium | 246 | 544 | 62 | $6,082 |
| Duloxetine Hcl Generic | 133 | 232 | 31 | $2,357 |
| Celecoxib Generic | 94 | 146 | 35 | $1,497 |
| Folic Acid Generic | 92 | 199 | 23 | $623 |
| Leflunomide Generic | 89 | 168 | 25 | $2,484 |
| Alendronate Sodium Generic | 77 | 180 | 20 | $633 |
| Sulfasalazine Generic | 71 | 170 | 19 | $2,431 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 65 | 150 | 16 | $672 |
| Methylprednisolone Generic | 62 | 117 | 29 | $1,364 |
| Allopurinol Generic | 55 | 136 | 14 | $502 |
| Pilocarpine Hcl Generic | 52 | 75 | 14 | $3,243 |
| Humira(Cf) Pen Adalimumab | 50 | 54 | Under 11 | $371K |
| Xeljanz Xr Tofacitinib Citrate | 47 | 55 | Under 11 | $301K |
Brand drugs: 427 claims; generic drugs: 2,094 claims; opioid claims: 86.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David S Korman $2,707 ($2,707 in general payments such as food, travel and fees) from 26 companies. The largest payer was UCB, Inc. with $373.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 20 | $373 |
| Amgen Inc. AMGN | 18 | $340 |
| AstraZeneca Pharmaceuticals LP AZN | 15 | $331 |
| Abbvie Inc. ABBV | 16 | $248 |
| E.R. Squibb & Sons, L.L.C. BMY | 16 | $242 |
| Janssen Biotech, Inc. JNJ | 7 | $143 |
| Pfizer Inc. PFE | 5 | $100 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $94.21 |
| Radius Health, Inc. | 5 | $92.67 |
| ANI Pharmaceuticals, Inc. ANIP | 4 | $81.4 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.